http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08502734-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-06 |
| filingDate | 1993-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08502734-A |
| titleOfInvention | Novel cephalosporin derivative and method for producing the same |
| abstract | (57) [Summary] The present invention relates to a novel cephalosporin derivative represented by the following general formula (I) useful as an antibiotic or a pharmaceutically acceptable non-toxic salt thereof, and a method for producing the same. General formula (1): In the formula, R 1 is hydrogen or an optionally halogen-substituted C 1-3 alkyl group, a propargyl group, or —C (R a ) (R b ) COOH (wherein R a and R b are independently hydrogen or Is a C 1-3 alkyl group), and R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently hydrogen or halogen or C 1-3 alkyl, amino or hydroxy C 1-3. It is an alkylthio, cyano, carbamoyl, carboxyl, hydroxy C 1-3 alkyl, nitro, acetyl or formyl group and Q is CH, N or CCl. |
| priorityDate | 1992-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 358.